Health Care Therma Bright (TSXV:THRM) partners with Ridge Global to expand its U.S. and global reach Therma Bright Inc. (THRM) has entered into a business agreement with Ridge Global. Brieanna McCutcheon 24 March 2021 13:00(EDT)
Health Care Market News Therma Bright (TSXV:THRM) enters into clinical trial agreement for its AcuVid COVID-19 rapid antigen test Therma Bright will conduct a clinical study of the company’s AcuVid TM rapid antigen test. John Ballem 26 February 2021 12:30(EDT)
Health Care Market News Therma Bright (TSXV: THRM) announces EU-CE approval for AcuVid COVID-19 rapid antigen saliva test and secures conditional sale of 100,000 CE-only AcuVid test kits Therma Bright Inc. (THRM) has received CE approval certification for its AcuVid™ COVID-19 rapid antigen saliva test. John Ballem 19 April 2021 09:15(EDT)
Health Care Therma Bright (TSXV:THRM) has added C$1,171,875 to its treasury Therma Bright Inc (THRM) has announced that in the past month, investors have exercised a total of 7,582,500 warrants and options. John Ballem 29 January 2021 10:45(EDT)
Health Care Therma Bright (TSXV:THRM) to develop COVID-19 saliva test Medical device company, Therma Bright (THRM) has formed a partnership with Orpheus Medica, to develop a COVID-19 saliva test. Elise Kelly 07 July 2020 15:40(EDT)
Health Care Therma Bright (TSXV:THRM) adds manufacturing expert to work on COVID-19 saliva tests Therma Bright (THRM) has added a veteran manufacturing expert to its advisory team to advance its saliva-based rapid antigen test. Isabella Zavarise 15 January 2021 13:20(EDT)
Health Care Market News Therma Bright (TSXV:THRM) applies to Health Canada for clinical study of COVID-19 saliva test Therma Bright (THRM) has applied to Health Canada to conduct a clinical study for its AcuVid COVID-19 saliva test. Trevor Abes 25 March 2021 11:00(EDT)
Technology Therma Bright (TSXV:THRM) takes control of its COVID-19 test Therma Bright (THRM) acquires 100 per cent control of its COVID-19 rapid saliva antigen test and mentions a proposed name change for said Brieanna McCutcheon 25 January 2021 06:30(EDT)
Health Care Therma Bright (TSXV:THRM) identifies new polypeptides in race for COVID-19 test Medical technologists Therma Bright (THRM) leapt up 17 per cent today, after identifying series of polypeptides for the detection of COVID-19. Joshua Peach 03 September 2020 15:36(EDT)
Health Care Therma Bright’s (TSXV:THRM) Brazilian performance study of its AcuVid™ COVID-19 Rapid Saliva-Based Antigen Test is complete Therma Bright’s (THRM) initial phase of the Brazilian study of the AcuVid™ saliva-based rapid antigen test has been completed. Brieanna McCutcheon 13 April 2021 18:00(EDT)
Therma Bright’s AcuVid COVID-19 test detects the Brazilian P.1 and P.2 and the UK B.1.1.7 variants Subscribe Be the first with the news that moves the market Therma Bright’s AcuVid COVID-19 test detects SARS-CoV-2 variants of concern; Brazilian P.1… John Ballem 22 April 2021 09:45(EDT) View Article
Therma Bright (THRM) brings in Barwicki Investor Relations Therma Bright (THRM) has signed an investor relations agreement with Barwicki Investor… Isabella Zavarise 29 December 2020 06:39(EDT) View Article
Therma Bright (TSXV:THRM) submits COVID-19 antigen test for approval Therma Bright (THRM) has submitted an application to the Research Ethics Board… Simon Druker 11 March 2021 12:00(EDT) View Article
Therma Bright (TSXV:THRM) begins clinical study for rapid COVID-19 antigen test Therma Bright (THRM) has initiated a clinical performance study for its AcuVid… Trevor Abes 18 March 2021 11:15(EDT)